MARKET

APM

APM

APTORUM GROUP
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.330
-0.070
-2.92%
After Hours: 2.360 +0.03 +1.28% 16:26 11/25 EST
OPEN
2.380
PREV CLOSE
2.400
HIGH
2.460
LOW
2.310
VOLUME
208.34K
TURNOVER
--
52 WEEK HIGH
18.25
52 WEEK LOW
1.160
MARKET CAP
79.25M
P/E (TTM)
-4.3333
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 9, 2020
Regulatory News: Aptorum Group Limited (Nasdaq: APM; Euronext Paris: APM) (the "Company", "Aptorum Group" or "Aptorum"), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, today announced it will hold its 2020 annual general meeting of shareholders at its Hong Kong office located at 17/F, Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong at 8:00 p.m. Hong Kong Time on December 9, 2020 (7:00 a.m. Eastern Standard Time on December 9, 2020 / 12:00 p.m. Greenwich Mean Time on December 9, 2020 / 1:00 p.m. Central European Time on December 9, 2020).
Business Wire · 10/16 12:00
Mometum Makes A Comeback As The Weather Cools Down
Momentum has re-entered the market with a vengeance, and it’s done so in one of my favorite months of the year both seasonally and, of course, in my trading returns. The past week has seen the stocks I focus on completely change their characteristics from the choppiness that took over through most of August and September.
Benzinga · 10/09 14:06
Aptorum Group Announces Closing of $9.0 Million Public Offering
Aptorum Group Limited (Nasdaq:APM, Euronext Paris:APM) ("Aptorum Group" or "Aptorum"), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, today announced the closing of a public offering of 2,769,231 Aptorum’s Class A ordinary
Business Wire · 10/02 21:05
Mid-Afternoon Market Update: Dow Jumps 350 Points; Iterum Therapeutics Shares Spike Higher
Toward the end of trading Wednesday, the Dow traded up 1.28% to 27,804 while the NASDAQ rose 0.83% to 11177.49. The S&P also rose, gaining 0.92% to 3,366.11.
Benzinga · 09/30 19:55
Mid-Day Market Update: Crude Oil Rises Over 1%; Aptorum Group Shares Plummet
Midway through trading Wednesday, the Dow traded up 1.76% to 27,934 while the NASDAQ rose 1.33% to 11,233. The S&P also rose, gaining 1.4% to 3,382.
Benzinga · 09/30 16:45
OAS, OMP, CTIC and NNDM among midday movers
Gainers: Iterum Therapeutics (ITRM) +146%.CTI BioPharma (CTIC) +110%.CynergisTek (CTEK) +69%.Nano Dimension (NNDM) +38%.Wanda Sports Group (WSG) +28%.Genetron (GTH) +24%.Allena Pharmaceuticals (ALNA) +20%.Sky Solar (SKYS) +19%.RAPT Therapeutics (RAPT) +19%.Limbach Holdings (LMB) +16%.Losers: Aptorum
Seekingalpha · 09/30 16:43
CTI BioPharma, Genetron Holdings leads healthcare gainers, Aptorum Group, Adial Pharmaceuticals among major losers
Gainers: CTI BioPharma (CTIC) +99%, Genetron Holdings (GTH) +26%, Allena Pharmaceuticals (ALNA) +23%, Neurotrope (NTRP) +20%, Kaleido Biosciences (KLDO) +11%.Losers: Aptorum Group (APM) -41%, Adial Pharmaceuticals (ADIL) -21%, Avalon GloboCare (AVCO) -15%, Galectin Therapeutics (GALT) -15%, Windtree Therapeutics (WINT) -13%.
Seekingalpha · 09/30 15:00
Mid-Morning Market Update: Markets Open Higher; Micron Issues Weak Earnings Forecast
Following the market opening Wednesday, the Dow traded up 1.29% to 27805.50 while the NASDAQ rose 0.95% to 11,190.17. The S&P also rose, gaining 0.96% to 3,367.52.
Benzinga · 09/30 14:11
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of APM. Analyze the recent business situations of APTORUM GROUP through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average APM stock price target is 13.00 with a high estimate of 15.00 and a low estimate of 11.00.
EPS
Institutional Holdings
Institutions: 11
Institutional Holdings: 97.63K
% Owned: 0.29%
Shares Outstanding: 34.01M
TypeInstitutionsShares
Increased
0
0
New
7
74.37K
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.02%
Pharmaceuticals & Medical Research
+0.82%
Key Executives
President/Executive Director
Darren Lui
Chief Executive Officer/Founder/Executive Director
Ian Huen
Chief Financial Officer
Sabrina Khan
Chief Operating Officer
Angel Ng
Executive Director
Clark Cheng
Other
Thomas Lee
Non-Executive Independent Director
Douglas Arner
Non-Executive Independent Director
Charles Bathurst
Non-Executive Independent Director
Mirko Scherer
Non-Executive Independent Director
Justin Wu
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About APM
Aptorum Group Limited is a pharmaceutical company dedicated to the discovery, development and commercializing of therapeutic assets to treat diseases, particularly infectious diseases and cancers (including orphan oncology indications). Through the establishment of drug discovery platforms, it enables the discovery of new therapeutics assets through systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. In addition to this, the Company is also pursuing therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women’s health and other disease areas. It also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Aptorum Group Ltd stock information, including NASDAQ:APM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading APM stock methods without spending real money on the virtual paper trading platform.